Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
RSC Medicinal Chemistry
|
November 15, 2021
<i>N</i>-Aryl mercaptoacetamides as potential multi-target inhibitors of metallo-β-lactamases (MBLs) and the virulence factor LasB from <i>Pseudomonas aeruginosa</i>
Samir Yahiaoui, Katrin Voos, Jörg Haupenthal, et al.
ACS Medicinal Chemistry Letters
|
July 21, 2022
Designing a Small Fluorescent Inhibitor to Investigate Soluble Epoxide Hydrolase Engagement in Living Cells
Steffen Brunst, Julia Schönfeld, Peter Breunig, et al.
Chemmedchem
|
June 29, 2021
Rh<sup>II</sup> -Catalyzed De-symmetrization of Ethane-1,2-dithiol and Propane-1,3-dithiol Yields Metallo-β-lactamase Inhibitors
Mikhail Krasavin, Daniil Zhukovsky, Igor Solovyev, et al.
Biochemical Pharmacology
|
July 30, 2022
Compilation and evaluation of a fatty acid mimetics screening library
Johanna H M Ehrler, Steffen Brunst, Amelie Tjaden, et al.
Journal of Medicinal Chemistry
|
February 21, 2022
<i>N</i>-Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-Lactamases
Cansu Kaya, Jelena Konstantinović, Andreas M Kany, et al.
Journal of Medicinal Chemistry
|
August 15, 2025
Sustainable Joullié-Ugi and Continuous Flow Implementation Led to Novel Captopril-Inspired Broad-Spectrum Metallo-β-Lactamase Inhibitors
Antonella Ilenia Alfano, Sveva Pelliccia, Simona Barone, et al.
Journal of Medicinal Chemistry
|
October 12, 2020
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
Kerstin Hiesinger, Jan S Kramer, Sandra Beyer, et al.
Journal of Medicinal Chemistry
|
November 24, 2021
Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase Inhibitors
Felix F Lillich, Sabine Willems, Xiaomin Ni, et al.
Journal of Medicinal Chemistry
|
August 23, 2019
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain
Jan S Kramer, Stefano Woltersdorf, Thomas Duflot, et al.
Journal of Medicinal Chemistry
|
June 18, 2025
Structure-Based Design of PROTACS for the Degradation of Soluble Epoxide Hydrolase
Julia Schönfeld, Steffen Brunst, Ludmila Ciomirtan, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
RSC Medicinal Chemistry
|
November 15, 2021
<i>N</i>-Aryl mercaptoacetamides as potential multi-target inhibitors of metallo-β-lactamases (MBLs) and the virulence factor LasB from <i>Pseudomonas aeruginosa</i>
Samir Yahiaoui, Katrin Voos, Jörg Haupenthal, et al.
ACS Medicinal Chemistry Letters
|
July 21, 2022
Designing a Small Fluorescent Inhibitor to Investigate Soluble Epoxide Hydrolase Engagement in Living Cells
Steffen Brunst, Julia Schönfeld, Peter Breunig, et al.
Chemmedchem
|
June 29, 2021
Rh<sup>II</sup> -Catalyzed De-symmetrization of Ethane-1,2-dithiol and Propane-1,3-dithiol Yields Metallo-β-lactamase Inhibitors
Mikhail Krasavin, Daniil Zhukovsky, Igor Solovyev, et al.
Biochemical Pharmacology
|
July 30, 2022
Compilation and evaluation of a fatty acid mimetics screening library
Johanna H M Ehrler, Steffen Brunst, Amelie Tjaden, et al.
Journal of Medicinal Chemistry
|
February 21, 2022
<i>N</i>-Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-Lactamases
Cansu Kaya, Jelena Konstantinović, Andreas M Kany, et al.
Journal of Medicinal Chemistry
|
August 15, 2025
Sustainable Joullié-Ugi and Continuous Flow Implementation Led to Novel Captopril-Inspired Broad-Spectrum Metallo-β-Lactamase Inhibitors
Antonella Ilenia Alfano, Sveva Pelliccia, Simona Barone, et al.
Journal of Medicinal Chemistry
|
October 12, 2020
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
Kerstin Hiesinger, Jan S Kramer, Sandra Beyer, et al.
Journal of Medicinal Chemistry
|
November 24, 2021
Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase Inhibitors
Felix F Lillich, Sabine Willems, Xiaomin Ni, et al.
Journal of Medicinal Chemistry
|
August 23, 2019
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain
Jan S Kramer, Stefano Woltersdorf, Thomas Duflot, et al.
Journal of Medicinal Chemistry
|
June 18, 2025
Structure-Based Design of PROTACS for the Degradation of Soluble Epoxide Hydrolase
Julia Schönfeld, Steffen Brunst, Ludmila Ciomirtan, et al.
Page
of 3